Aerpio Pharmaceuticals' Corporate Minority Round

Aerpio Pharmaceuticals raised a round of funding on March 17, 2017.

Aerpio Pharmaceuticals is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The Company's lead program, AKB‐9778, is a small molecule activator of the T…

Articles about Aerpio Pharmaceuticals' Corporate Minority Round: